HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Jung Kim Selected Research

Infections

10/2021Phytosphingosine induces systemic acquired resistance through activation of sphingosine kinase.
9/2020Drug use evaluation of opioid analgesics in pain management among patients with hematopoietic stem cell transplantation.
12/2018A 21.6 kDa tegumental protein of Clonorchis sinensis induces a Th1/Th2 mixed immune response in mice.
1/2017Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production.
11/2014Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program.
7/2014Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
4/2009The role of NF-kappaB factor REL2 in the Aedes aegypti immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Jung Kim Research Topics

Disease

67Neoplasms (Cancer)
04/2022 - 03/2008
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2009
18Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2008
15Breast Neoplasms (Breast Cancer)
10/2020 - 06/2011
13Neoplasm Metastasis (Metastasis)
10/2018 - 03/2008
12Lung Neoplasms (Lung Cancer)
01/2021 - 12/2008
10Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2011
9Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 10/2005
9Glioma (Gliomas)
04/2022 - 01/2011
7Infections
10/2021 - 04/2009
6Carcinoma (Carcinomatosis)
12/2020 - 03/2011
4Chronic Disease (Chronic Diseases)
11/2021 - 12/2018
4Death (Near-Death Experience)
10/2021 - 03/2014
4Pain (Aches)
09/2020 - 04/2016
4Astrocytoma (Pilocytic Astrocytoma)
10/2019 - 01/2011
3Dyspnea (Shortness of Breath)
04/2022 - 03/2015
3Brain Neoplasms (Brain Tumor)
04/2022 - 02/2018
3Lymphoma (Lymphomas)
12/2021 - 11/2019
3Pneumonia (Pneumonitis)
11/2018 - 12/2008
2Vomiting
04/2022 - 01/2021
2Diarrhea
04/2022 - 07/2018
2Constipation
04/2022 - 03/2015
2Nausea
04/2022 - 01/2021
2Anorexia
04/2022 - 07/2018
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 07/2017
2Melanoma (Melanoma, Malignant)
01/2021 - 11/2015
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2021 - 07/2017
2Human Influenza (Influenza)
11/2020 - 11/2020
2Oligodendroglioma
10/2019 - 10/2019
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2019 - 10/2017
2Alcoholism (Alcohol Abuse)
01/2019 - 04/2016
2Adenocarcinoma
01/2019 - 08/2017
2Clonorchiasis
08/2018 - 05/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2017 - 07/2015

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
10/2021 - 03/2008
11Temozolomide (Temodar)FDA LinkGeneric
04/2022 - 01/2011
10Biomarkers (Surrogate Marker)IBA
10/2022 - 12/2011
9Immune Checkpoint InhibitorsIBA
10/2022 - 11/2018
8Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2008
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2009
7PlatinumIBA
10/2018 - 03/2011
6Trastuzumab (Herceptin)FDA Link
12/2019 - 01/2008
5Tyrosine Kinase InhibitorsIBA
02/2021 - 07/2009
5Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 07/2014
5Phenobarbital (Luminal)FDA Link
11/2018 - 01/2017
4Anaplastic Lymphoma KinaseIBA
01/2022 - 10/2017
4Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 10/2013
4GemcitabineFDA Link
01/2021 - 09/2014
4Opioid Analgesics (Opioids)IBA
09/2020 - 04/2016
4Pemetrexed (MTA)FDA Link
11/2019 - 01/2009
4taxaneIBA
10/2018 - 01/2012
4human ERBB2 proteinIBA
06/2018 - 07/2012
4AntigensIBA
07/2017 - 01/2009
3EnzymesIBA
10/2021 - 01/2015
3Indicators and Reagents (Reagents)IBA
02/2021 - 10/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2011
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 02/2013
3Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 10/2019
3Progesterone Receptors (Progesterone Receptor)IBA
11/2018 - 06/2018
3Docetaxel (Taxotere)FDA Link
01/2018 - 11/2014
3Thymidylate SynthaseIBA
08/2017 - 12/2011
3Carcinoembryonic AntigenIBA
07/2017 - 01/2009
3Fluorouracil (Carac)FDA LinkGeneric
04/2014 - 02/2013
2Cetuximab (Erbitux)FDA Link
11/2022 - 12/2021
2Inosine Triphosphate (ITP)IBA
01/2022 - 07/2017
2Levetiracetam (Keppra)FDA LinkGeneric
01/2022 - 09/2015
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2021 - 10/2015
2pazopanibFDA Link
10/2021 - 01/2019
2B7-H1 AntigenIBA
02/2021 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 11/2019
2Peptides (Polypeptides)IBA
10/2020 - 01/2017
2AlpelisibIBA
09/2020 - 01/2020
2erucylphosphocholineIBA
06/2020 - 01/2018
2Procarbazine (Matulane)FDA Link
10/2019 - 10/2019
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2019 - 10/2019
2Lomustine (CCNU)FDA Link
10/2019 - 10/2019
2Morphine (MS Contin)FDA LinkGeneric
01/2019 - 04/2016
2Estrogen ReceptorsIBA
11/2018 - 06/2018
2Pharmaceutical PreparationsIBA
07/2018 - 01/2015
2Hormones (Hormone)IBA
10/2017 - 01/2017
2p21-Activated KinasesIBA
08/2017 - 07/2015
2Tumor Biomarkers (Tumor Markers)IBA
07/2017 - 01/2009
2CarbohydratesIBA
07/2017 - 01/2009

Therapy/Procedure

60Drug Therapy (Chemotherapy)
04/2022 - 10/2005
29Therapeutics
01/2022 - 01/2011
18Palliative Care (Palliative Therapy)
04/2022 - 08/2009
15Radiotherapy
04/2022 - 01/2011
10Adjuvant Chemotherapy
01/2022 - 03/2008
7Chemoradiotherapy
04/2022 - 04/2014
6Combination Drug Therapy (Combination Chemotherapy)
10/2019 - 09/2010
3Terminal Care (Care, Terminal)
01/2022 - 01/2019
3Salvage Therapy
10/2015 - 07/2014
3Neoadjuvant Therapy
01/2015 - 07/2011
2Immunotherapy
04/2022 - 09/2017
2Metastasectomy
12/2019 - 06/2011
2Gastrectomy
12/2019 - 06/2011
2Critical Care (Surgical Intensive Care)
01/2019 - 03/2014
2Adjuvant Radiotherapy
10/2018 - 06/2017